跳至主要内容
临床试验/CTRI/2025/12/098851
CTRI/2025/12/098851尚未招募3 期

A Randomized Comparative Trial on the efficacy of Arka Tail and Manashiladi Lepa in the management of vicharchika (SN43) (eczema).

DSRRAU JODHPUR1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年12月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
Any changes in EASI score

研究概览

简要总结

It is a randomized, prospective, open- label, interventional comparative clinical trial. the trial consist of two groups: one group will recieve Arka taila as external application. Other group will recieve Manahshiladi lepa as external application.  At the end of the study both groups will be compared for results.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Day(s) 至 60.00 Day(s)(—)
性别
All

入选标准

  • Diagnosed Patient of vicharchika according to subjective perameter of samhitas has complaints of itching, Burning sensation,discharge, dryness, eruption, and depigmentation.

排除标准

  • Patients suffering from disorders like diabetes Mellitus, systemic infections.
  • Age- below 12 years and above 60 years.
  • patients who are suffering from major psychiatric disorders.
  • Patients suffering from major systemic illnesses like myocardial infraction, Ischemic heart disease, AIDS, Cancer, Major respiratory disease, liver failure, Renal failure and Renal toxicity etc.

结局指标

主要结局

Any changes in EASI score

时间窗: 90 days

次要结局

  • Arka Tail and Manashiladi Lepa will provide a safe and effective treatment and improve the quality of life(90 days)

研究者

发起方
DSRRAU JODHPUR
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Rameshwar lal

PGIA JODHPUR

研究点 (1)

Loading locations...

相似试验